Company: IBACR
Filing Date: 2025-09-10
Form Type: DEF 14A
Source: 0001641172-25-026995
Chunk: 11

Company: IB Acquisition Corp.
Filing Date: 2025-09-10
Form: DEF 14A
Chunk 11
---
 of any third party for services rendered or products    
 sold to us, but only if such a third party or target business has not executed a waiver of      
 any and all rights to seek access to the Trust Account; and                                     |

| ● | the                                                                                              
 fact that none of our officers or directors has received any cash compensation for services      
 rendered to the Company, and all of the current members of our Board are expected to continue    
 to serve as directors at least through the date of the special meeting to vote on a proposed     
 business combination and may even continue to serve following any potential business combination 
 and receive compensation thereafter.                                                             |

Risk Factors

You should consider carefully all of the risks described in our Annual Report on Form 10-K filed with the SEC on December 26, 2024 and in the other reports we file with the SEC before making a decision to invest in our securities. Furthermore, if any of the following events occur, our business, financial condition and operating results may be materially adversely affected or we could face liquidation. In that event, the trading price of our securities could decline, and you could lose all or part of your investment. The risks and uncertainties described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that adversely affect our business, financial condition and operating results or result in our liquidation.

There are no assurances that the Extension will enable us to complete a business combination.

Approving the Extension involves a number of risks. Even if the Extension is approved, the Company can provide no assurances that a business combination will be consummated prior to the Deadline Date. Our ability to consummate any business combination is dependent on a variety of factors, many of which are beyond our control. If the Extension is approved, the Company expects to seek stockholder approval of a business combination. We are required to offer stockholders the opportunity to redeem shares in connection with the Extension Amendment and Trust Amendment, and we will be required to offer stockholders redemption rights again in connection with any stockholder vote to approve a business combination. Even if the Extension or a business combination are approved by our stockholders, it is possible that redemptions will leave us with insufficient cash to consummate a business combination on commercially acceptable terms, or at all. The fact that we will have separate redemption periods in connection with the Extension and a